Institutional Biosafety Committee (IBC)
Charge
The Institutional Biosafety Committee (IBC) is administered by the Office of the Vice Provost for Research and the Office of Research Assurances. The IBC must review and approve all research (funded and unfunded) and teaching projects involving:
- Use of recombinant DNA (including transgenic animals and plants),
- Pathogens (of humans, animals, or plants),
- Biological toxins, or
- Administration of unlicensed biological products to animals.
The purpose of these reviews is to provide for the safe conduct of work involving hazardous biological materials and to ensure compliance with applicable external regulations and Iowa State University policies.
The Committee serves as the Institutional Biosafety Committee in all matters involving recombinant DNA studies as required by the Federal Register, May 7, 1986, vol. 51, #88, pages 16958-16985, and subsequent guidelines which supersede earlier versions. The committee also reviews projects involving other hazardous biological materials.
Activity
Ongoing review of projects involving hazardous biological materials either performed at or sponsored by the University. Projects shall be conducted in a manner that does not pose significant risk to the health and safety of laboratory workers, the public, or the environment.
An annual report about the committee is filed with the National Institutes of Health, Office of Biotechnology Activities.
Current Members
| Name | Role | Representation | Start Term |
|---|---|---|---|
| Quisenberry, Sharron | Institutional Official (IO) | Vice President for Research & Economic Development | 01 Apr 2009 |
| Ament, Diane | Ex-officio | Office for Responsible Research | |
| Zamzow, Sarah | Administrator | Member Information Contact |
